Redmile Group as of March 31, 2018
Portfolio Holdings for Redmile Group
Redmile Group holds 64 positions in its portfolio as reported in the March 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Array BioPharma | 10.8 | $281M | 17M | 16.32 | |
Atara Biotherapeutics (ATRA) | 6.4 | $165M | 4.2M | 39.00 | |
Amicus Therapeutics (FOLD) | 6.2 | $162M | 11M | 15.04 | |
ImmunoGen | 3.9 | $102M | 9.7M | 10.52 | |
Xencor (XNCR) | 3.7 | $96M | 3.2M | 29.98 | |
Wave Life Sciences (WVE) | 3.5 | $90M | 2.2M | 40.10 | |
Alder Biopharmaceuticals | 3.2 | $83M | 6.5M | 12.70 | |
Avexis | 3.0 | $79M | 637k | 123.58 | |
Puma Biotechnology (PBYI) | 2.9 | $75M | 1.1M | 68.05 | |
WellCare Health Plans | 2.6 | $66M | 342k | 193.63 | |
Abbott Laboratories (ABT) | 2.5 | $66M | 1.1M | 59.92 | |
Fate Therapeutics (FATE) | 2.5 | $65M | 6.7M | 9.76 | |
Regenxbio Inc equity us cm (RGNX) | 2.5 | $64M | 2.1M | 29.85 | |
Penumbra (PEN) | 2.4 | $63M | 547k | 115.65 | |
Centene Corporation (CNC) | 2.3 | $60M | 560k | 106.87 | |
Anaptysbio Inc Common (ANAB) | 2.1 | $54M | 523k | 104.08 | |
Syneos Health | 2.1 | $54M | 1.5M | 35.50 | |
ICU Medical, Incorporated (ICUI) | 1.9 | $49M | 194k | 252.40 | |
Insmed (INSM) | 1.9 | $49M | 2.2M | 22.52 | |
Livanova Plc Ord (LIVN) | 1.8 | $46M | 518k | 88.50 | |
Irhythm Technologies (IRTC) | 1.8 | $46M | 730k | 62.95 | |
Bluebird Bio (BLUE) | 1.8 | $46M | 267k | 170.75 | |
Teleflex Incorporated (TFX) | 1.7 | $45M | 177k | 254.98 | |
Alexion Pharmaceuticals | 1.7 | $45M | 405k | 111.46 | |
Audentes Therapeutics | 1.5 | $39M | 1.3M | 30.05 | |
Cymabay Therapeutics | 1.5 | $38M | 3.0M | 12.99 | |
Glycomimetics (GLYC) | 1.4 | $37M | 2.3M | 16.23 | |
Epizyme | 1.4 | $36M | 2.0M | 17.75 | |
UnitedHealth (UNH) | 1.2 | $31M | 145k | 214.00 | |
Oxford Immunotec Global | 1.2 | $31M | 2.5M | 12.45 | |
Jounce Therapeutics | 1.0 | $26M | 1.2M | 22.35 | |
Nightstar Therapeutics | 1.0 | $25M | 1.8M | 14.37 | |
Array Biopharma Inc bond | 1.0 | $25M | 19M | 1.33 | |
Endologix | 1.0 | $25M | 5.9M | 4.23 | |
Inflarx Nv (IFRX) | 0.9 | $25M | 851k | 28.84 | |
Alder Biopharmaceuticals Inc convertible security | 0.9 | $23M | 25M | 0.92 | |
Syros Pharmaceuticals | 0.8 | $21M | 1.7M | 12.98 | |
Pra Health Sciences | 0.8 | $20M | 245k | 82.96 | |
Allscripts Healthcare Solutions (MDRX) | 0.8 | $20M | 1.6M | 12.35 | |
Chimerix (CMRX) | 0.8 | $19M | 3.7M | 5.20 | |
eHealth (EHTH) | 0.7 | $19M | 1.3M | 14.31 | |
Argenx Se (ARGX) | 0.7 | $19M | 239k | 80.44 | |
Heska Corporation | 0.7 | $19M | 238k | 79.07 | |
Deciphera Pharmaceuticals (DCPH) | 0.6 | $17M | 821k | 20.04 | |
Mylan Nv | 0.6 | $16M | 381k | 41.17 | |
Newlink Genetics Corporation | 0.6 | $15M | 2.1M | 7.25 | |
Odonate Therapeutics Ord | 0.5 | $13M | 594k | 21.18 | |
Teladoc (TDOC) | 0.4 | $11M | 273k | 40.30 | |
Armo Biosciences Ord | 0.4 | $11M | 299k | 37.41 | |
Invitae (NVTAQ) | 0.4 | $10M | 2.1M | 4.69 | |
Model N (MODN) | 0.4 | $9.5M | 524k | 18.05 | |
Cytomx Therapeutics (CTMX) | 0.4 | $9.5M | 335k | 28.45 | |
Universal Health Services (UHS) | 0.3 | $8.0M | 68k | 118.41 | |
Beigene (BGNE) | 0.3 | $6.7M | 40k | 168.00 | |
Petiq (PETQ) | 0.2 | $5.2M | 197k | 26.60 | |
Atyr Pharma Inc Common Stock Usd 0.001 | 0.2 | $5.0M | 1.9M | 2.65 | |
Aclaris Therapeutics (ACRS) | 0.1 | $1.9M | 107k | 17.52 | |
Ovid Therapeutics (OVID) | 0.0 | $1.1M | 161k | 7.07 | |
Accuray Incorporated (ARAY) | 0.0 | $145k | 29k | 5.00 | |
iShares Dow Jones US Health Care (IHF) | 0.0 | $330k | 2.1k | 158.12 | |
EXACT Sciences Corporation (EXAS) | 0.0 | $328k | 8.1k | 40.34 | |
Flexion Therapeutics | 0.0 | $223k | 9.9k | 22.46 | |
Horizon Pharma | 0.0 | $284k | 20k | 14.20 | |
Adverum Biotechnologies | 0.0 | $129k | 22k | 5.80 |